Skip to main content

December 2015

 

 

academics

 

Clinical research courses

Teva Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee recommended approval of reslizumab, a humanized anti-interleukin-5 (IL-5) IgG4K monoclonal antibody (mAb), in adult patients aged 18 years and older. Reslizumab is a targeted biologic therapy for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based treatment regimen.

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly’s cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck’s KEYTRUDA® (pembrolizumab) in a Phase I study across multiple tumor types. Based on the Phase I trial results, the collaboration has the potential to progress to Phase II trials in patients who have been diagnosed with either metastatic breast cancer or non-small cell lung cancer (NSCLC).

Walk in interview for asthma project at Vallabhbhai Patel Chest Institute - M.Pharm/M.Sc

The Vallabhbhai Patel Chest Institute (VPCI) is a unique postgraduate medical institution devoted to the study of chest diseases. It is a University of Delhi maintained institution and is funded entirely by the Ministry of Health and Family Welfare, Government of India. The institute is ideally located in the heart of the main campus of the University of Delhi, providing the requisite academic environment. The Institute fulfills the national need for providing relief to large number of patients in the community suffering from chest diseases. It has eminently discharged its role and has earned a unique place in the field of Chest Medicine. The main objectives of VPCI have been to conduct research on basic and clinical aspects of chest medicine, to train post graduates in Pulmonary Medicine and allied subjects, to develop new diagnostic technology and disseminate scientific knowledge related to Chest Medicine to other institutions in the country and to provide specialized clinical and investigative services to patients.

Post: Junior Research Fellow, Lab Attendant

Need of Project Fellow (M.Pharm/M.Sc/M.Tech) through TATA-CSIR-OSDD Fellowships

Applications are invited from Indian nationals for the project No: TCOF 9 “CDRI-830 Analogs Synthesis and Bioevaluation” for a period of six months and will be extended for another six months subject to review.

Post: Project Fellow

CCRH recruiting M.Pharm candidates to apply for Pharmacology & Pharmacognosy posts

The Central Council for Research in Homoeopathy (CCRH) invites applications for filling up of following posts on deputation including short-term contract basis:

Post: Assistant Director, Research Officer- Pharmacology

Walk in at National Botanical Research Institute for various postions

CSIR- National Botanical Research Institute (NBRI), Lucknow, a constituent laboratory of Council of Scientific & Industrial Research (CSIR), is a premier plant science research institute, involved in multidisciplinary R&D programmes of both basic and applied nature across scientific disciplines for economic, environmental and societal benefits for the people of India. CSIR-NBRI undertakes basic and applied research in strategically important areas of plant sciences.

NIRTH invites applications from Postgraduate degree in Life Science / Biotechnology for Malaria project

National Institute for Research in Tribal Health (NIRTH) formerly Regional Medical Research Centre for Tribals (RMRCT) is a permanent institute of Indian Council of Medical Research (ICMR) under Department of Health Research, Ministry of Health of Family Welfare, Govt. of India.

Career as Additional Director General/Scientist -H at ICMR

Indian Council of Medical Research, an autonomous organisation under Deptt. of Health Research M/o Health fit Family Welfare, Govt, of India, a premier research organisation dealing with health research, intends to fill up a vacant post of Additional Director General/Scientist -‘H’ in HAG pay scale of Rs. 67000- 79,000 by deputation/ absorption basis from the eligible persons from Ministries/ Departments of Central/State Governments and Autonomous Institutions.

Post: Additional Director General/Scientist -‘H’